Geron | GERN - Gross Profit On Sales


Geron reported $46.71M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Amgen USD 6.48B 307M Sep/2025
Bio Techne USD 191.28M 3.16M Dec/2025
Cassava Sciences USD -3.96M 1.16M Sep/2025
Cytokinetics USD 17.76M 15.82M Dec/2025
Esperion Therapeutics USD 140.59M 94.57M Dec/2025
Exelixis USD 572.18M 7M Dec/2025
Genmab DKK 977M 13M Dec/2025
Geron USD 46.71M 525K Dec/2025
Gilead Sciences USD 6.31B 106M Dec/2025
Incyte USD 1.39B 118.68M Dec/2025
MacroGenics USD 31.11M 30.14M Dec/2025
Novartis USD 10.25B 570M Dec/2025
Novavax USD 125.04M 76.09M Dec/2025